Clinical Trial Update: Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of simvastatin controlled-release (CR) and Zocor in patients with chronic kidney disease stages 3–5 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperlipidemia

Drugs mentioned

• Simvastatin CR (simvastatin)
• Zocor (simvastatin)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Chronic Kidney Disease, Hyperlipidemia | Phase 4 | Status: UNKNOWN